Danielle Renee Sterrenberg, M.D.

NPI 1023243748ActiveIndividual· Internal Medicine, Hematology & Oncology· Los Angeles, CA

Internal Medicine, Hematology & Oncology (M.D.) in Los Angeles, California, trained at University of Arkansas College of Medicine (class of 2009). Their prescriptions cost Medicare Part D more than their services did: $2,601,646 for 726 claims, against $111,628 paid for services in 2024. Astrazeneca Pharmaceuticals LP reported $30.74 in payments in 2025, mostly food and beverage.

Overview

NPI	1023243748
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	May 26, 2009
Last updated in NPPES	Nov 30, 2022
Certified by provider	Nov 30, 2022

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	C175342	CA
Internal Medicine, Hematology & Oncology	207RH0003X	036130788	IL

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026	No match	—
New York OMIG · Nov 4, 2026	No match	—
Ohio Medicaid · Nov 4, 2026	No match	—
Pennsylvania Medicheck · Nov 4, 2026	No match	—
Washington HCA · Nov 4, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (CA)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	337
Services billed	1,565 across 15 procedure codes
Paid by Medicare	$111,628

Part D prescriptions in 2024

Prescriptions (claims)	726 · 1,171 30-day fills
Patients	169
Total drug cost	$2,601,646
Generic share	72% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Arkansas College of Medicine
Graduation year	2009
Medicare specialty	Hematology/Oncology
Secondary specialties	Internal Medicine, Medical Oncology
Telehealth	Offers telehealth